The Influence of Exercise Dose, Exercise Intensity, and Weight Loss and Change in C-Reactive Protein in Sedentary Overweight Women by Tuite, Patrica K et al.
 THE INFLUENCE OF EXERCISE DOSE, EXERCISE INTENSITY, AND WEIGHT 
LOSS AND CHANGE IN C-REACTIVE PROTEIN IN SEDENTARY OVERWEIGHT 
WOMEN 
 
 
 
 
 
 
 
 
 
by 
Patricia K. Tuite 
 
BSN University of Pittsburgh, 1985 
 
MSN University of Pittsburgh, 1992 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
School of Education in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
University of Pittsburgh 
2012 
 
 ii 
UNIVERSITY OF PITTSBURGH 
SCHOOL OF EDUCATION 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
Patricia K. Tuite 
 
 
 
 
It was defended on 
August 3, 2012 
and approved by 
Lora Burke, PhD, MPH, RN, FAAN, Professor, Department of Health and 
Community Systems 
 
Paul Martin Coen, M.Sc, PhD, Assistant Professor, Department of Health and  
Physical Activity 
 
Richard Henker, PhD, RN, FAAN, Professor, Department of Acute and Tertiary Care 
 
Dissertation Advisor:   John M. Jakicic, PhD, Professor/Department Chairperson, 
Department of Health and Physical Activity 
 
 
        
       
         
 
 iii 
  
Copyright © by Patricia K. Tuite 
2012 
 iv 
 
Objective:    To examine the effect physical activity included in a weight loss program has on 
high sensitivity C-reactive protein (hs-CRP) levels in sedentary overweight women.    
Design, Setting, and Participants:  This study examined the change in hs-CRP in overweight 
and obese women in response to a 6 month behavioral weight loss program.  The parent study 
was a randomized trial involving 201 sedentary overweight women who participated in a weight 
control program, with data from 182 subjects available for this secondary analysis.     
Methods:  Participants were randomly assigned to 1 of 4 exercise groups based on energy 
expenditure (1000kcal/week or 2000 kcal/week) and intensity (vigorous vs. moderate).  Groups 
included: vigorous intensity/high dose; vigorous intensity/moderate dose; moderate 
intensity/moderate dose; and moderate intensity/high dose.  Participants were prescribed an 
energy restricted diet consisting of 1200 kcal/day or 1500 kcal/day and daily dietary fat intake 
between 20%-30% of total energy intake.   
Results:  There were no statistically significant differences between dose of exercise, moderate 
vs. high, (F=0.330, p=0.58) or level of intensity, moderate vs. vigorous (F=0.118, p=0.731) for 
change in hs-CRP. However, there was a significant decrease in hs-CRP from baseline to 6 
months (F=25.553, p<0.0004); there was a significant 3 way interaction between energy 
expenditure, intensity, and Pre/Post differences (F=4.035, p=0.035), post hoc analysis revealed a 
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significant decrease in hs-CRP in the moderate/high (p<0.0004) and vigorous/moderate groups 
(p=004).  The results were unchanged after controlling for the change in body weight, body 
fatness, or body distribution.  The change in hs-CRP was not significantly correlated with the 
change in body weight, percent body fat, waist circumference, or self-reported physical activity.  
hs-CRP at 6 months was correlated with 6 month measures of weight, BMI, percent body fat, 
and fat distribution (p<0.0004).   
Conclusions:   hs-CRP was reduced in overweight and obese women in response to a 6 month 
weight loss intervention that included a prescribed reduction in energy intake and a prescribed 
increase in exercise with a significant reduction in the moderate intensity/high dose and vigorous 
intensity/moderate dose groups.  Further research is needed to determine what effect exercise and 
or weight loss may have on markers of inflammation. 
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1.0  INTRODUCTION 
Obesity is a major health concern in the United States.  Obesity increases one’s risk for 
premature death from all causes by 50 to 100 percent with a projected 300,000 deaths per year1.  
Currently the prevalence of obesity exceeds 30% in most age groups and among both genders2. 
Being overweight is defined as having a body mass index (BMI) between 25 and <30 kg/m2 and 
obesity is defined as having a BMI ≥ 30 kg/m 2. The proportion of the population that is 
overweight or obese has been increasing. In 2003-2004, the overall prevalence of overweight and 
obesity in both men and women was estimated to be 66.3%3 increasing to 68% in 2007-20084. 
Recent examination of prevalence rates associated with obesity demonstrated that prevalence 
rates did not increase as originally anticipated.  Most recent results from the latest National 
Health and Nutrition Examination Survey (NHANES) demonstrated a stabilizing pattern.  In 
2009-2010, the age adjusted prevalence rates for men and women were 35.5% and 35.8% 
respectively2.  When examining the trends over the past 12 years, Flegal and colleagues2 found 
there was no significant increase in obesity among women overall from 1999 to 2010, but there 
were statistically significant changes among non-Hispanic black women and Mexican-American 
women. Men demonstrated a significant linear trend over the same time period.  When 
examining the last 2 years of data (2009-2010), there is no significant change in obesity 
prevalence when compared with the prior 6 years (2003-2008)2. The Nurses’ Health Study 
documented a 38 percent increase in obesity within that study cohort over time5.  Although the 
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prevalence of obesity has steadily increased, the prevalence previously observed over the past 10 
years does not seem to be continuing at the same rate especially for women2. Trends in obesity 
prevalence appear to be leveling off. 
Obesity has been identified as an independent risk factor for cardiovascular disease 
(CVD)6-10 and is associated with an increase in morbidity and mortality11.  The Nurse’s Health 
study demonstrated that mortality among obese women was more than twice that of lean women 
and that there was a 4-fold increase in cardiovascular deaths in women with a BMI > 29 kg/m2, 
12.  The National Health and Nutrition Examination Survey I (NHANES I) found that a higher 
weight in late middle age was associated with an increase in coronary heart disease (CHD) risk 
later in life13, while a BMI > 27 kg/m2 in middle age was also associated with an increased risk 
of CHD later in life, but did not pose an increased risk in old age.  The difference in risk was due 
to a weight loss of 10% between middle and old age.  Risk of CHD was also increased in 
individuals at a lower weight who had lost weight and heavier people who gained weight when 
compared to thinner people with stable weight13.  Poirier9 and colleagues reported that structural 
changes to the heart and alterations in function occur in individuals with excess adipose tissue, 
even in the absence of comorbidities. Poirier8 et al. concluded that the effect of obesity on the 
cardiovascular system predisposes one or is associated with cardiac complications such as CHD, 
heart failure, and sudden death.    
Improving overall fitness and increasing exercise capacity decreases cardiovascular risk 
factors and may result in up to a 35 percent reduction in CHD14-15. The Nurses’ Health Study is a 
large observational study designed to assess the effects of a combination of lifestyle habits on the 
risk of CHD in women5,16-18.  Results from the Nurses’ Health Study revealed that a woman was 
able to decrease the incidence of a coronary event by more than 80 percent if she did not smoke, 
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maintained a healthy weight (BMI < 25 kg/m2), consumed a healthy diet, participated in 
moderate to vigorous physical exercise for 30 minutes a day, and consumed a moderate amount 
of alcohol5,16.  Over the study’s 14-year observation period the incidence of CHD declined by 
31% across all age groups demonstrating that primary prevention can reduce the incidence of 
CHD. The study further demonstrated that the total physical activity score at baseline exhibited a 
strong inverse relationship with CHD19.   
To be effective, lifestyle modifications must be targeted at the underlying mechanism that 
contributes to the development of  CHD. The atherosclerotic process that leads to CHD has been 
identified as an inflammatory process20.  There are also certain biological risk markers that have 
been associated with CHD.  These include an elevation in  homocysteine levels, lipoprotein(a), 
and inflammatory markers such as high sensitivity C-reactive protein (hs-CRP), interleukin-6 
(IL-6), and tumor necrosis factor-α (TNF-α)21-24.   C-reactive protein (CRP)  is an acute phase 
protein, produced by hepatocytes and released during an inflammatory process25. It is 
recommended that hs-CRP assays be conducted in metabolically stable individuals, free of 
obvious inflammatory or infectious conditions.  The following hs-CRP values are associated 
with varying levels of risk that includes: low risk (<1.0 mg/L), average risk (1.0-3.0 mg/L), and 
high risk (>3.0 mg/L); values higher than 10.0 mg/L are thought to be from other inflammatory 
conditions20.  The 2010 guidelines established by the American College of Cardiologists and 
American Heart Association recommend the use of hs-CRP levels with global risk assessment 
for asymptomatic men and women identified as intermediate risk26.   Based on this information, 
the purpose of this study is to examine the effect that physical activity associated with weight 
loss has on high sensitivity C-reactive protein (hs-CRP) levels in sedentary overweight women.  
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1.1 RATIONALE 
Obesity is associated with an increase in circulating pro-inflammatory cytokines (interleukin-6, 
tumor necrosis factor-α) and C-reactive protein (CRP)27-28.  The adipose tissue acts as an 
endocrine organ with a high metabolic activity.  The adipocytes actively secrete hormones called 
adipokines which are associated with insulin resistance and atherosclerotic processes28-29.  Levels 
of adiponectin, which is an anti-inflammatory cytokine, are decreased in the presence of obesity 
further leading to the pro-inflammatory state29. A reduction in pro-inflammatory markers, such 
as CRP has been shown to be directly related to weight loss and change in waist circumference 
or truncal obesity27-28. 
Obesity is a modifiable risk factor associated with CHD and inflammation. Mounting 
evidence demonstrates that increasing physical activity can impact both CHD risk and the 
inflammatory process. An extensive body of evidence exists that supports the efficacy of 
exercise in decreasing the risk of CHD15-16,19,30-33, as well as research examining the effects of 
exercise on inflammatory markers in individuals without CHD32-35. Also, there is evidence 
demonstrating the decrease in inflammatory markers related to weight loss36-40.  
Two observational studies assessed the effects of exercise training in stable CHD patients 
and found a reduction in hs-CRP41 and a 50% decrease in CRP levels, as well as significant 
declines in interleukin -1 (IL-1) and IL-6 following 12 weeks of  aerobic exercise training in 
CHD patients42. Caulin-Glaser and colleagues43 were able to reproduce the results of the prior 
studies and showed that cardiac rehabilitation participation was able to decrease CRP levels even 
if there was not a decrease in triglycerides, body mass index or weight.     
Studies specifically targeting exercise demonstrated mixed findings.  Bo, Ciccone, Guidi, 
Gambino, Durazzo, Gentile, et al.44 demonstrated that CRP levels are inversely associated with 
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self-reported exercise after controlling for weight reduction.  However, results from clinical trials 
in which aerobic exercise was supervised for periods of 4 to 6 months showed no decrease in 
CRP in the presence of any weight loss45-46.  These new findings are contradictory to much of the 
cross-sectional and observational studies that showed individuals had reduced CRP levels with 
an increase in exercise.  There is a possibility that neither of these trials were long enough to 
show a change and that over a longer period of time a decrease in CRP level may be observed. 
Physical activity is commonly recommended as a component of a comprehensive weight 
loss intervention for overweight and obese adults.  Physical activity has been shown to result in 
approximately 1 to 3 kg of additional weight loss when added to weight loss achieved through 
dietary restriction alone47.  However, there is limited evidence to suggest that prescribing a 
higher dose of physical activity, from either an energy expenditure perspective or from an 
intensity of activity perspective will significantly improve weight loss compared to a moderate 
dose and moderate intensity of activity. For example, Jakicic et al.48-49  prescribed an energy 
restricted diet to overweight and obese adult women, with the women then randomized to one of 
four physical activity prescriptions that included 1000 kilocalories (kcals) at a moderate 
intensity, 1000 kcals at a vigorous intensity, 2000 kcals at a moderate intensity, or 2000 kcals at 
a vigorous intensity.  While weight loss was significant in all conditions at 6 months, there was 
no significant difference in the weight loss across the four exercise prescriptions.  However, what 
is unclear in the literature is whether prescribing physical activity at either a higher dose or a 
higher intensity within the context of a comprehensive behavior weight loss program will have 
differential effects on markers of CVD risk, particularly inflammatory markers such as CRP. 
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Thus, this study focused on a secondary analysis of existing data that included the 
additional analysis of banked blood samples for CRP in overweight and obese women (see figure 
1) and examined the following specific aims. 
 
     
  
  
 
 
Figure 1: Conceptual framework illustrating an intensity and dose of physical activity intervention 
on hs-CRP and behavioral weight loss program in sedentary overweight women. 
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on changes in CRP in overweight and obese women over a period of 6 
months. 
2. To compare the effect of varying prescribed doses and intensities of 
physical activity when combined with a prescribed energy restricted diet 
on changes in CRP in overweight and obese women over a period of 6 
months after controlling for changes in body weight. 
3. To compare the effect of varying prescribed doses and intensities of 
physical activity when combined with a prescribed energy restricted diet 
on changes in CRP in overweight and obese women over a period of 6 
months after controlling for changes in body fatness. 
4. To explore the association of self-reported physical activity dose and 
intensity of physical activity when combined with a prescribed energy 
restricted diet on changes in CRP in overweight and obese women over a 
period of 6 months. 
5. To explore the association of self-reported physical activity dose and 
intensities of physical activity when combined with a prescribed energy 
restricted diet on changes in CRP in overweight and obese women over a 
period of 6 months after controlling for changes in body weight. 
6. To explore the association of self-reported physical activity when 
combined with a prescribed energy restricted diet on changes in CRP in 
overweight and obese women over a period of 6 months after controlling 
for changes in body fatness. 
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2.0  SECOND CHAPTER 
2.1 INTRODUCTION 
This study focused on a secondary analysis of existing data that included the additional analysis 
of banked blood samples for hs-CRP in overweight and obese women in response to a 6 month 
behavioral weight loss program.  The parent study used a combination of exercise and reduced 
caloric intake to promote weight loss.  Women were randomized to one of four groups, this 
secondary analysis will enable the researcher to compare four different doses of exercise 
(varying intensity and energy expenditure) on hs-CRP in sedentary overweight women. The 
women were also instructed to reduce their caloric intake and dietary fat intake.  Determining the 
amount of weight loss necessary to decrease inflammation will provide health care professionals 
with the information necessary to counsel individuals on ways to promote a healthier lifestyle. 
Inflammation is associated with the development of CHD.  Decreasing levels of inflammation 
may result in a decrease in CHD risk, thus promoting participation in healthier lifestyle habits 
may decrease CHD risk in sedentary overweight women. There is a significant body of evidence 
that demonstrates that both obesity and a lack of physical activity are both risk factors for CHD 
and that decreasing obesity decreases inflammation that is associated with atherosclerosis. This 
literature review discussed the results and limitations of these prior studies providing a basis for 
the current study. 
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2.2 OBESITY PREVELANCE 
The prevalence of obesity has increased over prior years within the United States and has 
reached epidemic proportions.  In 2010, the Centers for Disease Control reported that 
approximately 72.5 million adults were obese within the United States50.  The most recent data 
from National Health and Nutrition Examination Survey (NHANES) identifies the current 
prevalence of obesity to be greater than 30 percent in most age groups and among both genders2.  
NHANES data has shown statistically significant increases in obesity in all age groups for both 
genders except men between the ages of 40-59 from 1999-20004; however, the most recent data 
demonstrated that prevalence rates have stabilized some and did not increase as much as 
originally anticipated2.  Data from 1994-1998 and 1999-2000 showed the prevalence of obesity 
increasing by 7.1 and 8.1 percentage points for men and women respectively4,51.  Based on 
earlier data, researchers presumed that prevalence rates would continue to increase by 6 to 7 
percentage points between 1999-2000 and 2008-2009, but after examining the NHANES data 
from 1999-2000 and 2007-2008, there was only an increase of 4.7 percentage points for men and 
2.1 percentage points for women4.  These data reflect more positive news than originally 
anticipated.  Based on current data, overall obesity prevalence is 33.8%; 32.2% and 35.5% for 
men and women respectively.  The corresponding prevalence rates for both overweight and 
obesity (BMI ≥ 25) were 68% overall, and 72.2% for men and 64.1% for women 4.  Further 
examination of the trends over the last 12 years, demonstrated no significant increases in obesity 
among women overall from 1999 to 2010, but did show statistically significant changes among 
non-Hispanic black women and Mexican-American women2.   Healthy People 2010 set a goal 
for all states to reach a prevalence rate of 15% for obesity, however no state met that goal as of 
200950.   
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The increasing prevalence of obesity has been clearly identified.  There are many other 
concerns associated with weight gain as well.  Obesity has been identified as a risk factor for 
CVD6-8,10-11.  Obesity is also associated with increasing medical costs within the United States.  
It is estimated that 147 billion dollars per year is spent on medical costs associated with obesity; 
this accounts for approximately 1,429 dollars per year for each obese individual as compared to 
individuals of normal weight52.  Based on these data, the Surgeon General’s Vision for Healthy 
and Fit Nation 2010 recommends a comprehensive approach to addressing increasing prevalence 
for obesity.  The Surgeon General recommends addressing both nutrition and physical activity, 
working across multiple settings and changing policy and environments to affect individual 
behaviors50. Improving physical activity plays a major role in improving health and decreasing 
weight. 
 
2.3 OBESITY AND INFLAMMATION 
Cottam et al.28 identified a strong association between obesity and inflammation depicting 
obesity as a chronic inflammatory state.  White adipose tissue serves as a major endocrine and 
secretory organ.  Adipocytes produce and secrete several proteins referred to as adipokines that 
act as hormones and play important roles as contributors to the inflammatory and atherosclerotic 
processes29,53-54.  Leptin, TNF-α, IL-6, angiotensinogen and plasminogen activator inhibitor-1 are 
all examples of pro-inflammatory adipokines29.  Elevated levels of these pro-inflammatory 
hormones have been noted in obesity resulting in a state of chronic inflammation28-29,55.  IL-6 
stimulates the formation of CRP in the liver23,54, thus obesity results in the increase in IL-6 
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leading to an increase in CRP.  Bastard et al.56 examined CRP and IL-6 levels in 13 fasting obese 
men and women and found a strong correlation between both CRP and IL-6 levels and adipose 
tissue.  Visser and colleagues57 also noted that higher BMIs were also associated with higher 
CRP concentrations.  Data from 16,616 men and non-pregnant women over the age of 17 from 
the Third National Health and Nutrition Examination Survey (NHANES III) were analyzed.  
Elevated CRP levels were more likely noted in individuals with BMIs > 27 kg/m2.  Waist to hip 
ratio was also positively associated with both elevated and clinically raised CRP levels in this 
population, independent of BMI57.   Mohamed-Ali and colleagues58  also identified that IL-6 was 
released by subcutaneous adipose tissue.  The presence of pro-inflammatory cytokines in 
overweight and obese individuals results in an increase in CRP levels suggesting that overweight 
and obese individuals experience chronic low grade systemic inflammation59.   There is evidence 
demonstrating that a reduction in fat mass correlates with a decrease in serum levels of many of 
the pro-inflammatory adipokines29,60.  Review of the literature performed by Cottam and 
associates28 further determined that weight loss resulted in a reduction of these markers and thus 
may lead to an improvement in the comorbidities associated with obesity such as CHD. 
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2.4 CHD IN WOMEN 
 
More than 200,000 women die each year from CHD61-62. CHD results in approximately a death a 
minute, and is the leading cause of death in women greater than 65 years of age12,61. In 2005, one 
out of every six female deaths was associated with CHD61.  
 Recent trends have shown an improvement in these statistics. Between 1980 and 2002, 
death rates from CHD among men and women greater than 65 years of age decreased by 52%  
and 49% in men and women, respectively. However, the decrease varied depending on age. 
Although, the death rate among women 35 to 55 years old decreased during the 1980’s and 
1990’s, the change was not sufficient to reach statistical significance, and more recently (2000-
2002)  the death rate increased slightly (1.5%)63. Of more concern, the CHD death rate in 
younger women, aged 35-44 years, increased by an average of 1.3% annually from 1997-200263. 
This change highlights the need to identify women at high risk and implement strategies to 
prevent CHD earlier than previously viewed as necessary.  
 Prior studies have identified evidence-based therapies successful in changing behavior to 
alter risk factors64. Two large cohort studies the Framingham Heart Study and the Nurses’ Health 
Study have provided significant observational data on risk factors. These results prompted many 
researchers to examine altering behavior to decrease CHD risk.   
 As previously mentioned the Nurses’ Health Study reported the effects of a combination 
of lifestyle practices on the risk of CHD in women5,16-18.  Results from the Nurses’ Health Study 
revealed that changing one’s lifestyle and adopting more healthy habits, specifically increasing 
physical activity and maintaining a healthy weight, resulted in a reduced incidence of coronary 
events by more than 80 percent5,16.  The incidence of CHD declined by 31% across all age 
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groups over the 14-year observation period demonstrating that a woman is able to decrease her 
CHD-associated risk profile. 
Some CHD risk factors are modifiable such as: age, ethnicity,  and family history.  
Smoking, dyslipidemia, hypertension, a sedentary lifestyle and obesity are proven risk factors for 
CHD that are modifiable10,65.  Extensive data exist demonstrating that alteration of these risk 
factors decreases the incidence of CHD10,65.   
 Smoking cessation has been identified as an important goal in the prevention of CHD.  
The Nurse’s Health Study clearly demonstrated a decrease in coronary events through reported 
changes in lifestyle including smoking cessation. The risk of CHD declined across all age 
groups, and these results were consistent with a decrease in smoking by 41%5.  Maintaining a 
blood pressure < 120/80 mm Hg is also optimal for the prevention of CHD and can be 
accomplished through weight control, increasing physical activity, using alcohol in moderation, 
restricting sodium  intake, and increasing the intake of fruits, vegetables, and low-fat dairy 
products10,65. Dyslipidemia is  controlled through lifestyle interventions such as increasing 
physical activity and maintaining a healthy diet and adjunctive pharmacotherapy as indicated10,65. 
Being overweight is a known and modifiable risk factor for CHD10.  The prevalence rates 
for both overweight and obesity (BMI ≥ 25) increased in 2007 -2008 data to 68% overall, and 
72.2% for men and 64.1% for women4.  In 2009-2010 the prevalence rate for men was 35.5% 
and 35.8% for women2. The Nurses’ Health Study documented a 38 percent increase in obesity, 
which appeared to slow the decline in CHD incidence noted in this study5. Notably, mortality 
among obese women was more than twice that of lean women and there was a 4-fold increase in 
cardiovascular deaths in women with a BMI > 29 kg/m2 13.  The National Health and Nutrition 
Examination Survey I (NHANES I) found that a heavier weight in late middle age was 
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associated with an increase in CHD risk later in life14, while a BMI > 27 kg/m2 in middle age 
was also associated with an increased risk of CHD later in life, but did not pose an increased risk 
in old age.  The difference in risk was due to a weight difference of 10% between middle and old 
age.  Risk of CHD was also increased in thinner people who had lost weight and heavier people 
who gained weight when compared to thinner people with stable weight14.    
 While concerning, there are evidence-based strategies that can decrease risk. Improving 
overall fitness and increasing exercise have been shown to result in up to a 35 percent reduction 
in CHD14-15. Manson and colleagues19 found that the total physical activity score at baseline 
exhibited a strong inverse relationship with CHD.  The more activity a woman participated in, 
the lower her risk for the development of CHD. There is also evidence that increasing physical 
activity and decreasing weight may result in a decrease in other risk factors associated with CHD 
at the mechanistic level, e.g. inflammation.  
 
 
2.5 INFLAMMATORY PROCESS 
 
To be effective, lifestyle modifications must be targeted at the underlying mechanism that results 
in CHD. The atherosclerotic process that leads to CHD has been identified as an inflammatory 
process20.  There are also certain biological risk markers that have been associated with CHD.  
These include an elevation in  homocysteine levels, lipoprotein(a), and inflammatory markers 
such as high sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis 
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factor α (TNF-α)21-24  . The presence of these inflammatory markers serves as predictors of 
higher risk for CHD21,23.  
 Atherosclerosis has been described as an inflammatory disease initiated by vascular 
injury that occurs from oxidized LDL and reactive oxygen species66.  In addition, the process is 
associated with the development and rupture of atherosclerotic plaque. During the acute phase 
response that occurs as a result of the inflammation, CRP and other markers of inflammation are 
released from the hepatocytes25.   
Various risk factors that promote the development of atherosclerosis have been identified 
e.g. cigarette smoking, hypertension, hypercholesteremia, and hyperglycemia. These risk factors 
give rise to noxious stimuli, which in turn elicits an inflammatory response20 .  Inflammation in 
the blood, either within the vessel or in the circulating blood volume, initiates the release of 
primary pro-inflammatory cytokines such as TNF-α and interleukin –1 (IL-1).   
These primary cytokines directly elicit the production of adhesion molecules, 
procoagulants, and other mediators from endothelial cells.  They also stimulate the production of 
IL-6, which serves as a messenger cytokine67.  The interleukins are “biochemical messengers 
produced predominately by macrophages and lymphocytes in response to their recognition of a 
pathogen or stimulation by other products of inflammation”68(p.196).  Pro-inflammatory cytokines 
produced mainly by macrophages include IL-1 and TNF-α.  IL-6 is a messenger cytokine, whose 
presence is crucial for leukocyte and endothelial cell activation.  It also promotes the production 
of hepatic acute-phase reactants, including CRP23.  C-reactive protein (CRP) is an acute phase 
protein produced by the liver in response to inflammatory cytokines such as IL-1 and IL-669.  C-
reactive protein may contribute to atherogenesis by causing the expression of cell adhesion 
molecules (CAMs) such as intercellular adhesion molecule-1 (ICAM-1), vascular adhesion 
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molecule-1 (VCAM-1), and selectins on the endothelial cells, thus mediating leukocyte adhesion, 
which is an early step in the formation of plaque70.  Thus, these markers can provide a picture of 
the inflammatory status of the individual. CRP may play a direct role in the development and 
progression of atherosclerosis70.   
 As early as 1930, C-reactive protein (CRP) was identified as occurring in response to the 
inflammatory process25.  Levels of CRP increase in response to trauma, infection and 
inflammation71.  In individuals without inflammation, the hs-CRP level is usually below 1 μg/ml, 
but in patients experiencing infection, autoimmune disease or cancer, the levels can be as high as 
100 μg/ml.  For patients with cardiac disease the predictive power lies in the range between 1 
and 5 μg/ml hs-CRP72.  Monitoring inflammatory markers can help to identify vulnerable 
individuals earlier and thus focus risk-reducing interventions on these individuals.   Thus 
addressing an individual’s lifestyle habits, e.g. regular physical activity or weight loss, may 
result in decreasing inflammation and decreasing the risk for CHD14-15,30-31.  
 
 
2.6 THE EFFECTS OF PHYSICAL ACTIVITY 
 
A report from the Surgeon General on physical activity and health states that more than 60% of 
American adults are not regularly physically active, and 25% are not physically active at all73.  
The same survey also identified that 54% of men and 66% of women age 75 years and older do 
not engage in any leisure-time physical activity73.  In 2004, data from a government conducted 
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survey in all 50 states found that approximately 21% of men and 26% of women reported no 
leisure-time physical activity74.  This is the lowest reported prevalence over the last 10 years.  
These latest data show improvement in prevalence rates, but still approximately one out of four 
individuals is not participating in any physical activity.  The highest level of leisure-time 
physical inactivity is among adults ≥ 70 years of age, with women being more physically 
inactive than men74-75.  When examining the incidence and prevalence of various chronic 
disorders the values are not all that different from the general population.  The prevalence of 
regular leisure time physical activity in individuals with cardiovascular disease is 30.1% overall; 
in males it is 31.4% and in females 29%62. 
Improving exercise capacity and fitness predicts more favorable outcomes in all-cause 
mortality76-77.  By improving overall fitness and increasing exercise capacity one can decrease 
cardiovascular risk factors, which may result in up to a 35 percent reduction in CHD15,78.  Pate 
et.al79 reported on numerous epidemiologic studies and controlled experimental investigations 
that demonstrated that physically active adults developed and maintained higher levels of 
physical fitness.  The improved physical fitness provides protective effects and improved risk 
factors for several chronic diseases including CHD, diabetes, and stroke.  Brown, Burton, and 
Rowan80 reviewed 10 years of literature and found a significant reduction in risk (28 to 58%) in 
cardiovascular outcomes.  They concluded that there is strong evidence for the role of physical 
activity in the primary prevention of cardiovascular disease as well as other chronic diseases80.   
The American Heart Association81 and the American College of Sports Medicine81 recommend 
that every adult should participate in a minimum of 150 minutes of moderate-intensity exercise 
during the week or a minimum of 20 minutes of vigorous intensity exercise three times per week 
to receive the associated health benefits.  An individual can also combine both moderate and 
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vigorous intensity activity for the same benefits81.  Increasing the amount of activity above these 
recommendations will provide additional health benefits. 
Yu and colleagues82 reported that in the Caerphilly study, 1,975 men between the ages of 
49 and 64 years of age did not show a decrease in CHD risk with leisure activity.  Only exercise 
classified as heavy or vigorous was associated with reduced risk of premature death from CHD.  
The intensity of physical activity reported by the subjects was classified as light or moderate 
intensity.  Thirty percent of the population reported no vigorous activity at all82.  This study 
focused on leisure activity and activity undertaken during work in an all male cohort.  The 
participants did not participate in an activity that was not within their usual routine.  One can 
conclude that an individual must increase his usual activity level to receive the cardioprotective 
benefits. 
Manson, Hu, Rich-Edwards, et al.17 examined the association between scores for physical 
activity, walking, and vigorous exercise and the risk of CHD in a cohort of 72,488 females  
enrolled in the Nurses’ Health Study.  Findings from this study were validated by the findings 
from the Women’s Health Initiative.  Data demonstrated that walking and vigorous exercise were 
associated with a decrease in CHD risk17.  The Women’s Health Initiative Observational Study 
enrolled 73,743 postmenopausal women to examine total physical activity score, walking, 
vigorous exercise, and hours spent sitting or sleeping as predictors of cardiovascular events19.  
They found that the total physical activity score at baseline exhibited a strong inverse 
relationship with CHD.  The more activity a woman participated in, the lower her risk for the 
development of disease.  Women, who exercised for 2.5 hours per week, by either walking or 
through vigorous exercise, had decreased their risk for CHD by 30 percent19.  This is consistent 
with the guidelines established by the Centers for Disease Control (CDC) and the American 
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College of Sports Medicine.  Risk was decreased further if the women participated in both 
vigorous activity and walking than either one alone.  Cardiovascular risk was decreased less in 
women who spent more time sitting or lying than those who moved around more19.  In summary, 
their findings indicated that both walking and vigorous exercise were associated with a decrease 
in cardiovascular events among postmenopausal women, regardless of race or ethnic group, age, 
and BMI.   
Lee and colleagues83 examined the relationship between physical activity, specifically 
walking, and the risk of CHD among women.  The Women’s Health Study recruited a cohort of 
39,372 healthy female health professionals aged 45 years or older.  Data indicated that at least 
one hour of walking per week predicted a lower risk for CHD.  This study indicated that even 
light-to-moderate activity is associated with lower CHD rates in women83.   Women that 
participated in 600 to1499 kcal/week had a significant decrease in CHD risk factors.  Increasing 
the amount of energy expenditure did not add additional risk reduction.  When women in the 
highest level of physical activity were compared with women in the lowest category, data 
showed a lower risk of CHD among the women who were most active83. 
 
 
2.7 EXERCISE AND INFLAMMATION 
 
Numerous studies outline the benefits of exercise on the risk of CHD, but there are few studies 
that examined the changes in cardiac inflammatory markers and the subsequent risk of CHD.  
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Bassuk and Manson32 determined that increased physical activity reduced cardiovascular risk 
independently of weight regulation. Thirty minutes of moderate-intensity activity lowered blood 
pressure, improved glucose tolerance and insulin sensitivity, and improved lipid levels, 
suggesting that the cardioprotective effects of exercise may be a result of the influence on 
inflammation and homeostasis. Bassuk and Manson33 also linked moderate-intensity exercise to 
reduced levels of the inflammatory marker CRP in both men and women.  Reductions in plasma 
fibrinogen levels and platelet aggregation and elevation in plasma tissue plasminogen activity 
were identified in men who participated in moderate-intensity exercise33, although these 
relationships have not yet been identified in women. Nicklas et al.34 found no significant effect 
of exercise on the CRP concentrations in older, overweight and obese, sedentary men and 
women, although CRP levels decreased more in men than women. These results differed from 
those identified by Bassuk & Manson33. Nicklas34 did recommend that further studies look at 
different modes and intensities of exercise on inflammation. 
Gielen84 (2005) described the anti-inflammatory effects of exercise. Two observational 
studies assessed the effects of exercise training on stable coronary artery disease (CAD) patients 
and found a reduction in hs-CRP41 and a 50% decrease  in CRP levels, as well as significant 
declines in IL-1 and IL-6 after aerobic exercise training in CAD patients42.  Milani and 
colleagues41 analyzed the effects of a cardiac rehabilitation program on hs-CRP in 277 patients 
and found a significant reduction in hs-CRP after a 3-month intervention.  The reduction in hs-
CRP was noted in patients who both gained and lost weight, implying that adipose tissue is not 
the only source of pro-inflammatory cytokines41.  Colbert and colleagues35 examined cross 
sectional data to determine the association between physical activity and inflammatory markers.  
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They concluded that higher levels of exercise were associated with lower levels of CRP, IL-6 
and TNF-α.. 
Caulin-Glaser and colleagues43 were able to reproduce the results of the prior studies and 
show that cardiac rehabilitation was able to decrease CRP levels even if there was not a decrease 
in triglycerides, body mass index or weight. Regardless of other cardiac risk factors, for example 
metabolic syndrome, CRP levels remained reduced after exercise in a cardiac rehabilitation 
program. These results are reassuring because the results were achieved in a “real world” setting 
recruiting patients as they were referred into the program; patients weren’t chosen because they 
were likely to be successful; and the study shows that underrepresented groups such as women 
and the elderly benefit equally well from the intervention84.   
In a recent prospective randomized trial, exercise training was compared with 
percutaneous angioplasty in 101 stable CAD patients85. The patients were either randomized to 1 
year of aerobic training or interventional therapy. After 12 months of training, hs-CRP levels 
were reduced by 36% in the exercise group. Hambrecht85 and colleagues were able to 
demonstrate that exercise alone is sufficient to decrease CRP levels resulting in a reduced risk of 
ischemic events.   
Prior studies within the cardiac rehabilitation patient population displayed a decrease in 
CRP levels with the exercise prescribed within the programs. Based on that evidence and those 
noted in other clinical trials86 Gielen84 hypothesized that the following 4 potential mechanisms 
are responsible for decreasing CRP levels:  1) reduction in central adiposity decreases adipocyte-
derived IL-6 and TNF-α; 2) improvement of endothelial dysfunction lowers endothelial IL-1 and 
IL-6 release; 3) reduced monocyte activation with simultaneous cytokine production; and 4) 
decreased cytokine production in other tissues, such as skeletal muscle.    
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As mentioned earlier in this paper, there is a developing body of evidence in the cardiac 
rehabilitation population demonstrating a decrease in CRP with exercise41-43.  Milani and 
colleagues41 demonstrated a decrease in hs-CRP levels with exercise regardless of weight 
change. Hambrecht et al.85 also noted a decrease in hs-CRP in patients only receiving an exercise 
intervention. These results are promising in terms of the response of exercise on the 
inflammatory process.  When researchers examined the effects of exercise on CRP in healthy 
individuals the results were not as favorable; results yielded no change in CRP with exercise87-88.  
Campbell, et al.87 found no intervention effects on CRP in both men and women who 
participated in a moderate to vigorous aerobic exercise intervention that were without serious 
medical conditions, but lived a sedentary lifestyle. The participants were randomized to either 
the intervention group or to the usual lifestyle group. The intervention included aerobic exercise 
for 60 minutes per day, 6 days per week for 12 months. The participants exercised at 60-85% of 
maximal heart rate. Usual diet was maintained throughout the trial.  The exercise intervention 
resulted in an increase in cardiopulmonary fitness, but no significant change in CRP. The 
participants did not experience a significant weight loss during this intervention87.   
Church and colleagues45 completed a randomized control trial designed specifically to 
measure CRP.  The objective of the study was to determine if an aerobic intervention without a 
dietary component would decrease CRP in patients with an elevated CRP levels45.  They 
recruited 162 sedentary men and women with elevated CRP levels (between 2.0 mg/L and 10 
mg/L) and no history of serious medical illnesses. The participants were randomized to either the 
no exercise control group or the exercise training group.  The exercise dose was set at 16 kcal/kg 
body weight divided among three to five sessions per week completed in an exercise laboratory 
60%-80% VO2max45.  Participants did not experience weight loss during this intervention. Thus, 
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researchers determined that exercise training without weight loss resulted in no change in CRP 
levels among participants.  Researchers did note a 12% increase in fitness levels among those in 
the exercise group.  Stewart and colleagues46 completed a randomized control trial examining 
four different exercise interventions, none of the interventions resulted in a decrease in CRP 
levels.  The participants that completed the most exercise (12kcal/kg/week) presented with the 
greatest weight loss, this weight loss was associated with a decrease in CRP levels.  Based on 
these findings the researchers concluded that weight loss not exercise is associated with a 
reduction in CRP levels46 .   
Two other randomized control trials utilizing exercise as an intervention resulted in a 
reduction in CRP levels among participants.  Lakka and colleagues completed the HERITAGE 
family study.  The study was a 20 week exercise intervention study in five universities in the 
United States and Canada89.  The intervention included an exercise training program consisting 
of three sessions per week on cycle ergometers in an exercise laboratory.  Participants initially 
exercised for 30 minutes at 55% of their maximal heart rate, after 2 weeks, the exercise sessions 
were increased to 50 minutes at 75% of maximal heart rate.  That level was sustained for the last 
six weeks of the study89.  A total of 652 sedentary men and women were included in the analysis. 
The participants were stratified into three groups related to baseline CRP levels: low (CRP < 1.0 
mg/L), moderate (CRP levels 1.0 mg/L – 3.0 mg/L) or high (CRP levels > 3.0 mg/L).  Results 
indicated a reduction in CRP levels in individuals with high baseline CRP levels (> 3.0 mg/L) 
after adjusting for changes in body weight, glucose, insulin, low density lipoprotein (LDL) and 
high density lipoprotein (HDL) cholesterol levels, triglycerides, systolic and diastolic blood 
pressure, and maximal oxygen uptake89.   
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Campbell and colleagues90 examined the effect of a 12 month moderate intensity aerobic 
intervention on CRP in a subset of 115 postmenopausal women recruited for another study.  The 
women were randomized into either the exercise group or the control group which consisted of 
45 minutes of stretching per week.  Randomization was stratified by BMI to ensure equal 
number of both obese and lighter participants per group (BMI < 27.5 kg/m2 or ≥ 27.5 kg/m2)91. 
The participants exercised for 45 minutes at 60%-75% of maximal heart rate.  During the first 3 
months, the participants attended 3 supervised sessions and exercised 2 days at home; for months 
4-12 participants attended at least 1 supervised exercise session and completed exercising at 
home for the other 4 days. Over the 12 month period, those in the intervention group averaged 
3.8 days of exercise per week for 166 minutes/week.  Participants in the intervention group 
increased aerobic fitness, decreased body weight, and decreased percent body fat when compared 
with the control group90.  Results demonstrated a decrease in CRP levels in the exercise group 
among sedentary post-menopausal women with BMI ≥ 27.5 kg/m2. 
A cross-sectional design examined 152 overweight/obese postmenopausal women who 
were sedentary and free of chronic or inflammatory diseases91.  Researchers compared total 
energy expenditure (TEE), physical activity energy expenditure (PAEE) and the resting energy 
expenditure (REE).  Results demonstrated that hs-CRP was positively associated with REE and 
that women with the highest tertile of PAEE (1233-1319 kcal/day) had the lowest concentrations 
of hs-CRP when compared to the lowest tertile of PAEE (553-621 kcal/day) after adjusting for 
fat mass91. 
The above studies demonstrated conflicting results related to exercise and CRP levels.  
When participants were stratified according to BMI or level of baseline CRP, there was a 
significant decrease in CRP levels.  Although, Church et al.45 recruited participants with mean 
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BMIs of approximately 31 kg/m2, and mean baseline CRP levels of 4.9 mg/L, and the 
researchers still found no change in CRP levels in the intervention group.  These results conflict 
with the results from the Campbell et al.90 and Lakka et al.89.  Investigating the role that weight 
loss plays in the decrease in the CRP may yield differing results.  Lavoie et al.91 also 
demonstrated a decrease in CRP with higher levels of physical activity, but this was a cross 
sectional design not a randomized trial. 
 
2.8 WEIGHT LOSS AND INFLAMMATION 
 
2.8.1 Surgical Interventions 
Selvin et al.92 completed a systematic review analyzing the relationship between CRP and weight 
loss. The reviewed spanned 40 years and included 33 studies, 28 studies involving a lifestyle 
intervention and 5 involving surgical intervention. The surgical studies demonstrated a mean 
change in weight of negative 33.1 kg with a decrease in CRP level of 4.5 mg/L. The studies 
utilizing a life style change as the intervention, the mean weight loss across studies was 6.2 kg 
with a mean decrease in CRP levels of 0.9 mg/L92.  After analyzing all of the studies, the 
correlation between mean baseline weight and mean CRP level was 0.76 (weighted Pearson 
correlation (r), and when examining the regression slope the overall change was 0.13 mg/L 
decline in CRP for each 1 kg of weight loss (weighted r=0.85)92.  On average, they found that the 
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largest change in weight was associated with the greatest decrease in CRP levels, thus 
concluding that weight loss may be effective in decreasing markers of inflammation. 
As illustrated in the systematic review by Selvin92, gastric bypass surgery was successful 
in demonstrating a decrease in CRP levels.  A study completed  by Ramalho, Guimarães, Gil, 
Neves, Guimarães and Delgado93 enrolled 32 morbidly obese females undergoing laparoscopic 
gastric banding surgery.  At baseline, the mean weight and BMI was 114.3 ±11.6 kg and 43.4 
±4.4 kg/m2, respectively; 18 months after surgery, weight and BMI were 80.5± 16.0 kg and 
30.5± 6.1 kg/m2, resulting in a 63.2% excess body weight loss.  One month after surgery, CRP 
levels began to decline resulting in significant decrease in CRP levels at 18 months post 
surgery93.   
2.8.2 Dietary Interventions 
Two additional studies utilized a low caloric diet to promote weight loss and analyzed the effect 
on CRP levels94-95 Solá and colleagues94 compared 67 morbidly obese patients with 67 healthy 
subjects.  The intervention group received a very low caloric diet for four weeks followed by a 
low caloric diet for two months.  The participants were able to obtain a moderate weight loss 
(19.6%), but there was no decrease in CRP noted94. 
Belza et al.95enrolled 33 obese patients into a 20 week controlled dietary intervention.  
The intervention was divided into four sections:  a low energy liquid diet (3.4 MJ/day) for the 
first 8 weeks, participants reduced body weight by 8 percent followed by a 4 week maintenance 
program.  During the next 4 weeks, participants followed a low energy liquid diet of 4.2 MJ/day.  
Participants were allowed to supplement with 750 kJ/day of free food choice items during the 
second weight loss period.  The second weight loss period was followed by another 4 weeks of a 
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weight maintenance period.  There was no change in hs-CRP after the first 8 weeks of the diet, 
but there was a 35% reduction in hs-CRP after the second weight loss period95. The researchers 
concluded that a reduction of fat mass may be responsible for the decrease in inflammatory 
marker. 
An additional study demonstrated conflicting results with the two low energy diets 
presented above. Tchernof, Nolan, Sites, Ades, and Poehlman37 enrolled 61 obese 
postmenopausal women into a weight loss protocol. The subjects consumed a 1200 kcal/day 
American Heart Association Step 2 diet for approximately 13.9±2.6 months prior to metabolic 
testing.  Reductions in both body weight (average weight loss – 14.5±6.2 kg) and total body fat 
mass were associated with a decrease in plasma CRP levels37. These results are not consistent 
with the prior studies, but the diet was followed for a longer period of time in this particular 
study. 
 
2.8.3  Diet and Exercise Combinations 
Various studies have shown a decrease in inflammatory markers associated with weight 
loss34,38,96-97.  Nicklas and colleagues34 completed an 18 month randomized control trial 
examining the effects of diet, exercise and a combination of diet and exercise among older, 
sedentary, overweight or obese men and women.  They concluded that diet-induced weight loss 
had more of an effect on inflammatory markers than exercise alone. Esposito et.al.38   
randomized 120 pre-menopausal obese women in Italy to one of two groups to determine if 
changes in one’s lifestyle habits can reduce body weight and inflammatory markers over a two-
year time period.  Serum concentrations of CRP were significantly reduced in the intervention 
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group.  They concluded that a multidisciplinary program that reduced body weight in obese 
women through lifestyle changes (diet and exercise) did reduce inflammatory markers and 
insulin resistance. Giannopoulou and colleagues39 found little change in inflammatory cytokines 
(hs-CRP, TNF-α) with diet and exercise in older women with type 2 diabetes, thus concluding 
that dramatic weight loss or clinical intervention is needed. The sample size in that particular 
study was very small with only 33 women.  
Two additional studies demonstrated decreases in CRP levels with weight loss of 
approximately five to seven percent96-97. Christiansen et al96, compared exercise training versus a 
diet-induced weight loss program in 79 obese healthy men and women. The participants were 
randomized to an exercise group, a low calorie diet group, or a combination of diet and exercise.  
Participants in both the low calorie diet and combined diet and exercise group lost about twice as 
much weight as the participants in the exercise only group.  A reduction in CRP levels was 
associated with the increased weight loss96. The Look Ahead study, a large randomized control 
trial of individuals with type 2 diabetes examined a subset of individuals enrolled in the study to 
evaluate a life style intervention that targeted a seven percent weight loss among the 
participants97.  Participants were randomized to a control group that received diabetes support 
and education or the intervention group.  The intervention group began an exercise regimen of 
moderate-intensity exercise, which was increased to 175 minutes/week and was placed on a 
reduced calorie diet consisting of decrease in saturated fat intake and changes in macro nutrient 
composition to improve glycemic control.  After one year, participants in the intervention group 
had a seven percent weight loss resulting in a significant decrease in hs-CRP. 
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2.9 SUMMARY 
 
Obesity is a major health concern within the United States.  Albeit, prevalence rates have 
stabilized and have not increased over the last couple of years, obesity continues to be a risk 
factor for many disease states.  Obesity is a major risk factor for CHD and CHD is the leading 
cause of death among both men and women.  The increase in adipose tissue in the obese state 
results in the secretion of pro-inflammatory adipokines such as: leptin, TNF-α, and IL-6.  IL-6 
stimulates the release of CRP resulting in an inflammatory state.  Elevated CRP levels have been 
identified in states of chronic inflammation.  Researchers have identified that physical activity 
may play a role in decreasing CRP levels.  There is a significant body of literature demonstrating 
that increasing physical activity decreases CHD risk17,19,80,82-83 and recommendations from the 
American College of Sports Medicine and the American Heart Association suggest participating 
in at least 150 minutes of moderate intensity exercise or 75 minutes of vigorous intensity 
exercises per week will result in an improved state of health81.  Numerous cross sectional studies 
have demonstrated an inverse relationship between physical activity and CRP levels, whereas 
exercise intervention studies have shown conflicting results32-34,86. Two randomized control trials 
utilizing exercise as the intervention resulted in no significant reduction in CRP levels among the 
participants45-46, whereas two other trials did show a decrease in CRP levels89-90.  There were 
changes in CRP levels noted in patients receiving cardiac rehabilitation41-43.  Reductions in CRP 
levels were also noted in individuals who are obese or those who displayed higher levels of 
inflammation (CRP levels > 3.0 mg/L)89.  
Weight loss has been identified in the reductions of CRP levels.  Significant weight loss 
from bariatric surgery has resulted in a decrease in CRP levels92 whereas additional trials 
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demonstrated conflicting results related to dietary interventions such as low calorie diets.  
Interventions that incorporated both diet and exercise resulting in weight loss appeared to reduce 
CRP levels38-39.  It also appears that the greater the weight loss the greater the decrease in CRP 
level.  
There is a significant body of literature examining weight loss and exercise in relation to 
decreasing CRP levels.  Based on these results, exercise alone does not appear to decrease CRP 
levels in overweight and obese healthy individuals, although decreases in CRP levels were noted 
in the cardiac rehabilitation patient population, patients with osteoarthritis, and those with type 2 
diabetes.  A decrease in CRP levels was also noted in participants of weight loss studies and in 
studies that combined weight loss and exercise.  Most of the studies used a consistent form of 
exercise, most often of moderate intensity.  What was not clear is whether or not varying the 
intensity of the exercise along with the amount of energy expended during the exercise affected 
CRP levels.  Literature does not demonstrate whether or not altering the prescribed dose of 
exercise in combination with an energy restricted diet resulted in a greater decrease in CRP 
levels.  Thus, this study conducted a secondary analysis of existing data that included the 
additional analysis of banked blood samples for hs-CRP in overweight and obese women in 
response to a 6- month behavioral weight loss program to determine if intensity or amount of 
energy expended during exercise resulted in a decrease in CRP levels signifying a decrease in 
inflammation.   
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3.0  METHODS 
 
Physical activity, in combination with an energy restricted diet, is commonly recommended as a 
component of a comprehensive weight loss intervention for overweight and obese adults.  
Physical activity has been shown to result in approximately 1 to 3 kg of additional weight loss 
when added to weight loss achieved through dietary restriction alone47.  However, what is 
unclear in the literature is whether prescribing physical activity at either a higher dose or a higher 
intensity within the context of a comprehensive behavior weight loss program had differential 
effects on markers of CVD risk, particularly inflammatory markers such as high sensitivity c-
reactive protein (hs-CRP).  Thus, this study conducted a secondary analysis of existing data that 
included the additional analysis of banked blood samples for hs-CRP in overweight and obese 
women in response to a 6 month behavioral weight loss program.   
This study involved a secondary analysis of 6 month data from a previously published 
clinical trial48-49.  In addition, stored blood samples were analyzed for hs-CRP to address the 
specific aims of this study.  The methods and procedures are described below.     
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3.1 METHOD FROM THE PARENT STUDY 
 
3.1.1 Subjects 
Two hundred and four sedentary overweight or obese females were assessed for eligibility for 
this study, with 201 randomized into 1 of 4 groups as described below.  For the purpose of this 
study only subjects who provided blood samples were included in the analysis.  Thus, 182 
subjects were included in this secondary analysis. 
Eligibility criteria included being female with a baseline age between 21 to 45 years and 
with a baseline BMI between 27.0 and <40 kg/m2.  At baseline individuals were determined to be 
ineligible based on the following criteria: 
1. History of myocardial infarction 
2. Taking medication that would alter the heart rate response during exercise (e.g., beta 
blockade) 
3. Taking medications that would affect metabolism or weight loss (e.g. thyroid 
medication) 
4. Currently receiving treatment for psychological conditions (e.g., depression, anxiety, 
etc.) 
5. Currently pregnant or recently pregnant within the previous six months 
6. Currently diagnosed with any medical condition that could affect metabolism or body 
weight (e.g. diabetes, hypothyroidism, etc.) 
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7. Currently experiencing any condition that would affect one’s ability to perform 
exercise. 
8. Participating in regular exercise of at least 20 minutes per day on 3 or more days of 
the week during the prior 6 months. 
3.1.2 Recruitment, Initial Screening, and Informed Consent 
Subjects were recruited through newspaper advertisements that were approved by the local 
Institutional Review Board.  Individuals responding to these advertisements were instructed to 
call the investigators by telephone to obtain further information about the study.  Upon receipt of 
a telephone call the staff provided a brief description of the study, with individuals interested in 
participation after hearing this description answering questions to determine initial eligibility 
based on the criteria listed above.  Individuals who appeared to be eligible based on this initial 
telephone screening were invited to an orientation session where the study was explained in 
greater detail, components of informed consent were explained, and the individual was given the 
opportunity to ask additional questions of the investigators.   
Prior to undergoing any experimental procedures for this study written informed consent 
was obtained from the potential subject, and the individual completed both a detailed medical 
history and a physical activity readiness questionnaire to confirm that no conditions were present 
that would exclude participation.  Moreover, prior to undergoing any experimental procedures, 
individuals also provided clearance from their personal physician stating that it was safe to 
participate in a weight loss intervention that included a reduced energy intake diet and exercise.     
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3.1.3  Research Design and Randomization 
Following baseline assessments to confirm eligibility and to collect additional study-related data, 
eligible individuals were randomly assigned to one of four weight loss intervention conditions.  
These weight loss interventions included the following: 
1. Weight loss that included an energy restricted diet and exercise prescribed to progress 
to a moderate dose (1,000 kcal/wk) and moderate intensity (MOD/MOD). 
2. Weight loss that included an energy restricted diet and exercise prescribed to progress 
to a moderate dose (1,000 kcal/wk) and vigorous intensity (MOD/VIG). 
3. Weight loss that included an energy restricted diet and exercise prescribed to progress 
to a high dose (2,000 kcal/wk) and moderate intensity (HIGH/MOD). 
4. Weight loss that included an energy restricted diet and exercise prescribed to progress 
to a high dose (2,000 kcal/wk) and vigorous intensity (HIGH/VIG). 
The details of each of these interventions are described below. 
 
3.1.4 Behavioral Weight Loss Intervention 
For the purpose of this study only the initial 6 months of the intervention and data collection 
were included.  Therefore, the 6 month weight loss intervention that was implemented in the 
parent study is described below and has previously been published (Jakicic et al. 2003). 
Intervention Sessions:  Subjects in all intervention conditions were instructed to attend 
weekly weight loss group session.  These groups were closed to only those participants randomly 
assigned to a particular intervention condition (MOD/MOD, MOD/VIG, HIGH/MOD, 
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HIGH/VIG).  These intervention sessions focused on behavioral strategies to reduce energy 
intake and to increase exercise consistent with the intervention protocol.  Sessions were led by a 
variety of professionals that included health psychologist, nutritionists, and exercise 
physiologists.  These sessions were scheduled weekly during the six month intervention period.  
If a group session was missed, a brief individual make-up session was offered to allow the 
content to be shared with the subject.  Body weight was measured at each of these intervention 
sessions to determine responsiveness of the subject   Subjects unable to attend either the group 
session or the make-up session were mailed intervention materials that may have been 
distributed to the other subjects who were able to attend the schedule session. 
Diet Intervention:  The identical dietary intervention was provided to all subjects 
regardless of randomized intervention assignment (MOD/MOD, MOD/VIG, HIGH/MOD, 
HIGH/VIG).  This included prescribing subjects to consume between 1200 and 1500 kcal per 
day, and to reduce their dietary fat intake to between 20 and 30 percent of their total energy 
intake.  Meal plans were provided to facilitate adoption and compliance with these dietary 
recommendations.  In addition, subjects self-monitored their dietary intake in a food diary that 
was returned to the intervention staff at each intervention session, with the intervention staff 
reviewing these diaries and providing written feedback relative to self-reported eating behavior.  
Exercise Intervention:  The exercise prescription differed between the randomized 
intervention conditions (MOD/MOD, MOD/VIG, HIGH/MOD, HIGH/VIG), with these exercise 
interventions varying by estimated energy expenditure (1000 kcal/wk versus 2000 kcal/wk) and 
exercise intensity (moderate versus vigorous).  The targeted estimated energy expenditure of the 
exercise was converted to minutes per week based on the differences in exercise intensity that 
were prescribed.  A summary of the exercise prescription is shown in Table 1, with the exercise 
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for each intervention condition described briefly below.  To facilitate compliance, subjects were 
instructed to exercise in bouts that were at least 10 minutes in duration.  Because exercise was 
not supervised on site, motorized treadmills were placed in the homes of all subjects to facilitate 
compliance with the prescribed exercise prescription, and the weekly intervention sessions 
addressed strategies to promote exercise adherence. 
MOD/MOD: Subjects in the MOD/MOD treatment group were instructed to exercise 5 
days per week, and to progress from 20 to 40 minutes of exercise per day by the 9th week of the 
program (approximately 1000 calories per week).  The exercise intensity was prescribed at 50-
65% of age-predicted maximal heart rate, and subjects were taught the proper technique of 
palpating their heart rate and use of the Borg 15-point Rating of Perceived Exertion (RPE) Scale 
to regulate exercise intensity. 
MOD/VIG:  Subjects in the MOD/VIG treatment group were instructed to exercise 5 
days per week, and to progress to 30 minutes of exercise per day (approximately 1000 calories 
per week).  The exercise intensity was prescribed at 70-85% of age-predicted maximal heart rate, 
and subjects were taught the proper technique of palpating their heart rate and use of the Borg 
15-point Rating of Perceived Exertion (RPE) Scale to regulate exercise intensity.  
HIGH/MOD:  Subjects in the HIGH/MOD treatment group were instructed to exercise 5 
days per week, and to progress from 20 to 60 minutes of exercise per day by the 17th week of the 
program (approximately 2000 calories per week).  The exercise intensity was prescribed at 50-
65% of age-predicted maximal heart rate, and subjects were taught the proper technique of 
palpating their heart rate and use of the Borg 15-point Rating of Perceived Exertion (RPE) Scale 
to regulate exercise intensity. 
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HIGH/VIG:
 
  Subjects in the HIGH/VIG treatment group were instructed to exercise 5 
days per week, and to progress from 20 to 40 minutes of exercise per day by the 9th week of the 
program (approximately 2000 calories per week).  The exercise intensity was prescribed at 70-
85% of age-predicted maximal heart rate, and subjects were taught the proper technique of 
palpating their heart rate and use of the Borg 15-point Rating of Perceived Exertion (RPE) Scale 
to regulate exercise intensity. 
Table 1: Exercise Prescription for the Four Treatment Conditions48 
 
 
 
Exercise Intervention Groups 
MOD/MOD MOD/VIG HIGH/MOD HIGH/VIG 
Frequency 5 days/week 5 days/week 5 days/week 5 days/week 
     
Intensity 
(%HRmax) 
    
• Weeks 1-8 50-65% 50-65% 50-65% 50-65% 
• Weeks 9-16 50-65% 60-75% 50-65% 60-75% 
• Weeks 16-24 50-65% 70-85% 50-65% 70-85% 
• Weeks 25-104 50-65% 70-85% 50-65% 70-85% 
     
Duration (min/day)     
• Weeks 1-4 20 min/day 20 min/day 20 min/day 20 min/day 
• Weeks 5-8 30 min/day 30 min/day 30 min/day 30 min/day 
• Weeks 9-12 40 min/day 30 min/day 40 min/day 40 min/day 
• Weeks 13-16 40 min/day 30 min/day 50 min/day 40 min/day 
• Weeks 17-20 40 min/day 30 min/day 60 min/day 40 min/day 
• Weeks 21-24 40 min/day 30 min/day 60 min/day 40 min/day 
• Weeks 25-104 40 min/day 30 min/day 60 min/day 40 min/day 
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3.1.5 Assessment Procedures 
Within the parent study that is providing data to address the specific aims as described in Chapter 
1, outcome data were collected at baseline and following the 6 month weight loss intervention.  
The assessments included measurements of demographic characteristics (e.g., race/ethnicity, age, 
etc.), height, weight, body mass index (BMI), body composition, body fat distribution, dietary 
intake, and physical activity.  The investigator on this current project was provided a de-
identified dataset containing these outcome measures.  In addition, the investigator on this 
current project was provided a de-identified sample of stored serum that was analyzed for hs-
CRP to address the primary aims of this investigation.  The specific procedures used to assess the 
outcomes measures are described below. 
Height, Weight, and BMI:  Height was measured to the nearest 0.25 inches using a 
wall-mounted stadiometer with shoes of the subject removed. Weight was measured to the 
nearest 0.25 pounds on a balance-beam scale with the subject clothed in a light-weight hospital 
gown.  BMI was computed as kg/m2, where kg represents body weight converted to kilograms 
and m2 represents height converted to meters and then squared. 
Body Composition:  Body composition was assessed using bioelectrical impedance.  
The equation proposed by Segal et al.98 was used to compute lean body mass (LBM), with 
percent body fat computed as:  Percent Body Fat = [(weight – LBM)/weight]*100.   
Body Fat Distribution:  Body fat distribution was assessed using anthropometry.  Waist 
circumference was measured in duplicate, with measures differing by <1.0 cm, at the level of the 
umbilicus using a Gulick measurement tape.  Hip circumference was measured in duplicate, with 
measures differing by <1.0 cm, at the widest protuberance of the buttocks using a Gulick 
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measurement tape.  Waist-to-hip (WHR) was computed as the waist measurement divided by the 
hip measurement. 
Dietary Intake:  Dietary intake was measured using the Block Food Frequency 
Questionnaire (FFQ).99-100.   This questionnaire was used to assess the usual frequency of 
consumption of specific foods and typical portion sizes. The FFQ was used to obtain information 
on mean daily energy intake and macronutrient composition (carbohydrate, protein, fat)99-100. 
Physical Activity: Self-reported physical activity was assessed using the Paffenbarger 
Physical Activity Questionnaire101.  The Paffenbarger questionnaire was used to determine 
energy expenditure during participation in leisure-time physical activity.  Participants were 
queried on daily average number of flights of stairs walked up, average daily walking performed 
for the purpose of exercise, and any sport, recreational, or fitness activities the subject engaged in 
over the previous week typical week.  Activity was converted to energy expenditure based on 
metabolic equivalents (METs) provided in the compendium of physical activity99.  The 
Paffenbarger questionnaire has been shown to provide an acceptable level of validity and 
reliability102. 
Serum Samples:  Serum samples were collected at baseline and 6 months.  These 
samples were collected in the morning with subjects instructed to fast and abstain from 
moderate-to-vigorous physical activity for a period of 12-hours prior to blood collection.  
Compliance with these instructions was confirmed by questioning the subject prior to blood 
collection.  Blood was drawn into evacuated tubes containing EDTA, sodium heparin, or SST 
clot activator.  Baseline and 6-month samples have been stored in a -70° C freezer.  hs-CRP will 
be measured by a solid-phase, chemiluminescent immunometric assay (Immulite 2000 High-
Sensitivity CRP; Diagnostics Products Corporation, Los Angeles, CA).  All blood samples were 
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processed at the Heinz Nutrition Laboratory in the Graduate School of Public Health at the 
University of Pittsburgh.   
 
3.2 STATISTICAL ANALYSIS PLAN 
 
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) 
software, version 20. Statistical significance will be set at P<0.05.  Data was examined for 
normality prior to analysis, with data determined to not be normally distributed analyzed using 
non-parametric statistical techniques. 
Descriptive baseline data were expressed as mean ± standard deviation for continuous 
variables, or expressed as frequencies for categorical variables.  The randomized intervention 
groups were compared on baseline demographic variables using one-way analysis of variance 
(ANOVA) for continuous variables or chi-square analysis for categorical variables.  The data 
analysis plan for each of the specific aims of this study was performed as described below. 
1. To compare whether there is an effect of exercise intervention on change in hs-CRP, 
a two-factor (Group X Time) ANOVA was performed.  Group was defined based on 
randomization assignment (MOD/MOD, MOD/VIG, HIGH/MOD, HIGH/VIG) and 
time defined as baseline (0 months) or 6 months. 
2. To compare whether change in weight influences the effect of exercise intervention 
on change in hs-CRP, analysis of covariance (ANCOVA) was performed controlling 
for change in body weight. 
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3. To compare whether change in body fatness influences the effect of exercise 
intervention on change in hs-CRP, analysis of covariance (ANCOVA) was performed 
controlling for either change in percent body fat or change in body fat distribution. 
4. To examine the association between change in self-reported physical activity and 
change in hs-CRP, correlation coefficients were computed. 
5. To examine if the association between change in self-reported physical activity and 
change in hs-CRP is influenced by change in body weight, partial correlation 
coefficients were computed controlling for change in body weight. 
6. To examine if the association between change in self-reported physical activity and 
change in hs-CRP is influenced by change in body fatness, partial correlation 
coefficients were computed controlling for either change in percent body fat or body 
fat distribution. 
 
3.3 POWER ANALYSIS 
 
A power analysis was conducted based on the primary aim of this study, which was to examine 
the difference in hs-CRP between the four exercise conditions that were implemented in the 
parent study.  Based on a fixed effects ANOVA, the power analysis indicated that 40 participants 
in each of the 4 groups would provide 80% power to detect a near modest effect size for 
interaction between intensity and duration of exercise (f=.26) at a significance level of 0.05.  
Based on the retention in each of the intervention conditions for this study (MOD/MOD, 
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MOD/VIG, HIGH/MOD, HIGH/VIG), there is sufficient sample to detect this effect size in this 
proposed study.  
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4.0  RESULTS 
 
The purpose of this study was to complete a secondary analysis of existing data to examine the 
effect of four different prescribed doses of exercise (varying intensity and energy expenditure), 
combined with a prescribed reduction in calorie intake, on change in hs-CRP in overweight and 
obese sedentary women.  Moreover, this study examined whether a change in weight or body 
fatness influenced the observed effect of exercise on hs-CRP. 
 
4.1 SUBJECTS CHARACTERISTICS 
 
The sample consisted of 182 subjects who provided a measure of hs-CRP from the original 201 
subjects included in the parent study48-49.  As designed in the parent study, subjects were 
randomized into one of four exercise groups.  Table 2 provides a summary of the demographic 
variables, serum values, and measures of weight, body fatness, fat distribution, and amount of 
activity participation for the total sample and stratified by weight category. 
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Table 2: Demographic Characteristics for Total Subjects by Treatment Group 
 Total 
n= (182) 
(Mean±SD) 
HIGH/VIG 
(n=49) 
(Mean±SD) 
HIGH/MOD 
(n=42) 
(Mean±SD) 
MOD/MOD 
(n=45) 
(Mean±SD) 
MOD/VIG 
(n=46) 
(Mean±SD) 
P 
value* 
Age (yrs) 37.5±5.6 38.9±5.5 37.7±5.0 37.1±6.1 36.3±5.7 0.13 
Height (cm) 163.5±6.4 163.4±6.5 163.8±7.5 163.1±5.7 163.5±5.9 0.97 
Baseline weight (kg) 87.5±13.3 87.7±10.9 86.8±14.4 87.2±13.1 88.2±15.0 0.97 
BMI (kg/m2) 32.7±4.2 32.9±3.9 32.2±4.0 32.7±7.0 32.9±4.7 0.87 
Waist circumference (cm) 99.3±11.7 100.5±10.5 100.1±13.4 96.3±11.2 100.2±11.8 0.27 
Body Fatness (%) 41.4±5.0 41.4±4.0 41.2±4.0 41.7±5.0 41.3±6.0 0.97 
Total Cholesterol (mg/dL) 193.4±32.1 197.1±6.9 187.5±30.8 196.1±37.2 194±33.4 0.51 
High density lipoprotein (mg/dL) 52.5±12.7 53.1±12.0 50.1±10.6 54.7±15.7 52±11.8 0.40 
Low density lipoprotein (mg/dL) 118.9±29.2 120.9±26.6 114.8±28.8 121.4±32.6 118.4±29.5 0.71 
Triglyceride (mg/dL) 115.8±64.6 115.8±55.9 113.3±48.0 115.4±86.3 118.7±64.5 0.99 
Glucose (mg/dL) 102.6±9.0 101.7±8.3 101.4±10.1 102.2±10.1 104.9±10.3 0.30 
Insulin (mcU/mL) 18.1±8.6 18.3±9.2 17.2±7.6 17.3±9.3 19.2±8.4 0.65 
hsCRP mg/L 5.5±4.9 5.5±5.0 5.9±6.4 5.2±4.3 5.4±3.9 0.93 
Physical Activity Energy Expenditure  
(kcal/week) 
533±721.0 458±862.0 545±592.0 482±605.0 652±772.0 0.57 
 N (%) N (%) N (%) N (%) N (%)  
Ethnicity    
American Indian or Alaskan Native 
Black 
Hispanic, Latino, Portuguese, or Cape 
Verdean 
Native Hawaiian or Pacific Islander 
White 
Other 
 
1(0.5) 
14(8) 
16(9) 
 
1(0.5) 
147(81) 
2(1) 
 
1(0.5) 
3(2) 
1(0.5) 
 
0 
43(24) 
0 
 
0 
2(1) 
1(0.5) 
 
1(0.5) 
38(21) 
0 
 
0 
8(4) 
6(3) 
 
0 
30(16) 
1(0.5) 
 
0 
1(0.5) 
8(4) 
 
0 
36(20) 
1(0.5) 
.02** 
Employment Status  
Working 
Not working 
Employment/ Job     
Professional, administrative, executive 
Clerical work, administrative support, sales 
or technician 
Crafts, trade, factory worker, service, or labor 
Other 
Not Working      
Homemaker 
Student 
Currently not Employed 
 
166(91) 
2(1) 
 
74(41) 
66(36) 
 
11(6) 
15(8) 
 
13(7) 
3(2) 
2(1) 
 
42(23) 
1(0.5) 
 
19(1) 
15(8) 
 
4(2) 
5(3) 
 
5(3) 
1(0.5) 
0 
 
39(21) 
1(0.5) 
 
16(9) 
22(12) 
 
1(0.5) 
0 
 
2(1) 
1(0.5) 
0 
 
41(23) 
0 
 
18(10) 
13(7) 
 
4(2) 
5(3) 
 
3(2) 
0 
2(1) 
 
44(24) 
0 
 
21(12) 
16(9) 
 
2(1) 
5(3) 
 
3(2) 
1(0.5) 
0 
.56** 
 
 
.28** 
 
 
 
 
 
.33** 
Marital Status   
Married 
Separated 
Divorced 
Widowed 
Never Married 
 
115(63) 
5(3) 
14(8) 
3(2) 
45(25) 
 
33(18) 
3(2) 
3(2) 
0 
10(5) 
 
30(16) 
0 
3(2) 
1(0.5) 
8(4) 
 
24(13) 
1(0.5) 
6(3) 
0 
14(8) 
 
28(15) 
1(0.5) 
2(1) 
2(1) 
13(7) 
.38** 
Education      
High School 
Vocational Training 
Some College (<4yrs) 
College/University Degree 
Graduate or Professional education 
 
29(16) 
9(5) 
72(40) 
48(26) 
24(13) 
 
11(6) 
1(0.5) 
17(9) 
13(7) 
7(4) 
 
6(3) 
4(2) 
17(9) 
10(5) 
5(3) 
 
6(3) 
3(2) 
18(10) 
12(7) 
6(3) 
 
6(3) 
1(0.5) 
0 
13(7) 
6(3) 
.91** 
*p-values are based on statistical tests comparing the 4 intervention groups; ** p-value for Pearson Chi-Square 
analysis 
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The sample included women who were sedentary, overweight or obese (BMI: 32.7± 4.4 
kg/m2; percent of body fat 41.4% ± 5.0) prior to initiating the intervention, and were 37.5±5.6 years 
of age.  The majority of the sample reported themselves as white (81%), married (63%), and 
working (91%) in either a professional (41%) or clerical work (36%) position.  The majority of 
subjects (79%) reported themselves as having some college education, with 39% completing a 4 
year degree or graduate or professional education.  The mean hs-CRP for all subjects is 5.5± 4.9 
mg/L.  C-reactive protein levels > 3.0 mg/L are considered to place one at a higher risk for CHD 
when combined with other risk factors20.   
Analysis of variance revealed no differences between the intervention groups for baseline 
age, weight, BMI, waist circumference, body fatness, serum levels or baseline activity.  Chi-square 
analysis revealed no difference between groups for marital status, employment status, and 
educational status.  There was a significant difference in category of ethnicity between the groups 
(p<0.023).  However, these results have to be tempered by the fact that greater than 20% of the cells 
have expected frequencies less than 5, a violation of one of the assumptions of the Chi-Square 
analysis. 
Figure 2 illustrates the mean change in physical activity energy expenditure (PAEE) and 
energy intake (kcal/day) from baseline to 6 months.  There was a significant decrease in energy 
intake (kcal/day) for all groups (p<0.0004), with the range of the mean change being 661 kcals/day 
to 745 kcals/day. There was not a significant difference between the groups for the change in energy 
intake from baseline to 6 months (p=0.92).  There was a significant increase in PAEE for all groups 
(p<0.0004), the range of the mean change being 914 kcals/week to 1770 kcals/week. There was not 
a significant difference between the groups for the change in PAEE from baseline to 6 months 
(p=0.13). 
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Figure 2: Change in Energy Intake (kcal/day) and Physical Activity Energy Expenditure 
(kcal/week) Between Treatment Groups from Baseline to 6 Months 
 
Participants exercised at either a moderate or vigorous intensity.  There was a significant 
exercise intensity effect (p<0.001)48.  The rating of perceived exertion was higher in the vigorous 
intensity/high dose and vigorous intensity/moderate dose groups than the moderate intensity/high 
dose and moderate intensity/moderate dose groups.  Mean scores based on the BORG 15-point RPE 
scale for each group are as follows:  HIGH/VIG 12.7 ± 1.1, MOD/VIG 12.8 ± 1.2, HIGH/MOD 
12.0 ± 1.4 and MOD/MOD 11.6 ± 2.048.  There was also a significant effect for heart rate, a 
significant exercise intensity effect (p=0.002).  Results for heart rate were as follows:  HIGH/VIG 
127.4 ±10.8 beats per minute, MOD/VIG 128.7 ± 10.3 beats per minute, HIGH/MOD 117.0 ± 11.8 
beats per minute, and MOD/MOD 120.2 ± 13.0 beats per minute48. 
 
  
 
-1000 
-500 
0 
500 
1000 
1500 
2000 
2500 
Vig/High Mod/High Mod/Mod Vig/Mod 
Treatment Group 
Change in Energy Intake 
(Kcal/day) 
Change in Physical Activity 
Energy Expenditure 
(kcal/week) 
 47 
4.2 COMPARISON OF THE EFFECT OF EXERCISE BY TREATMENT GROUP ON 
HS-CRP 
 
The effect of the exercise intervention on change in hs-CRP was examined using a two-factor 
(Group x Time) analysis of variance with repeated measures. Analysis of variance revealed that 
there were no statistically significant differences for hs-CRP between level of energy expenditure, 
moderate vs. high, (F=0.330, p=0.58) or level of intensity, moderate vs vigorous (F=0.118, 
p=0.731).  There was a statistically significant difference between Pre and Post values of hs-CRP 
(F=25.553, p<0.0004), see Table 3.  This finding however, must be interpreted in light of the fact 
that there was also a statistically significant 3 way interaction between energy expenditure, 
intensity, and Pre/Post differences (F=4.035, p=0.035), see Table 4. A Least Square-Differences 
post-hoc analysis of the 3 way interaction showed that the change in hs-CRP from baseline to 6 
months was statistically significant for the HIGH/MOD (p<0.0004) and the MOD/VIG (p=0.004) 
groups, with a trend towards statistical significance for the MOD/MOD (p=0.063) group.  There 
change in hs-CRP was not statistically significant for the HIGH/VIG (p=0.278) group.  (Figure 3 
and Table 3) 
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Figure 3: Mean change in hs-CRP Baseline to 6 Months 
 
 
 
 
 
Table 3: Change in hs-CRP Values from Baseline to 6 Months 
Treatment 
Group 
hs-CRP 
(mg/L) 
Baseline 
hs-CRP 
(mg/L) 
6 Months 
Change in 
hs-CRP 
Baseline to 
6 months 
Time Effect Treatment 
Effect 
 
Time X 
Treatment 
Effect 
Mean± 
Standard 
Deviation 
Mean ± 
Standard 
Deviation 
Mean ± 
Standard 
Deviation 
F 
value 
P- 
value 
F 
value 
P-
Value 
F 
value 
P-
value 
High/Vig 
(N=49) 
5.54±4.98 5.02±4.61 0.52±2.38 25.553 0.0004 0.216 0.885 1.905 0.13 
High/Mod 
(N=42) 
5.85±6.39 3.75±5.36 2.10±4.86 
Mod/Mod 
(N=45) 
5.16±4.25 4.23±3.9 0.93±2.54 
Mod/Vig 
(N=46) 
5.37±3.85 3.93±2.65 1.44±3.12 
Total (N=182) 5.47±4.89 4.26±4.22  
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Table 4: Interaction Between Change in hs-CRP,  PAEE, & Intensity of Exercise 
Outcome 
Variable 
HIGH/VIG 
(N=49) 
(Mean±SD) 
HIGH/MOD 
(N=42) 
(Mean±SD) 
MOD/MOD 
(N=45) 
(Mean±SD) 
MOD/VIG 
(N=46) 
(Mean±SD) 
Time Effect 
(BL to 6M) 
Time X 
PAEE 
Time X 
Intensity 
Time, PAEE& 
Intensity 
F-
value 
P-
value 
F-
value 
P-
value 
F-
value 
P-
value 
F-
value 
P-
value 
hs-CRP 
baseline 
5.54±4.98 5.85±6.39 5.16±4.25 5.37±3.85 
5.553 0004 .65 80 .188 28 .525 035 
hs-CRP 6 
mos. 
5.02±4.61 3.75±5.36 4.23±3.9 3.93±2.65 
Change 
from 
baseline 
-0.52±2.38 -2.10±4.86 -0.93±2.54 -1.44±3.12         
p-value for 
the change 
from 
baseline 
0.28 <0.0004 0.063 0.004         
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4.3 INFLUENCE OF CHANGE IN WEIGHT ON THE EFFECT OF THE EXERCISE 
INTERVENTION ON CHANGE IN CRP 
 
The mean percent change in weight for the subjects from baseline to six months is illustrated in 
Figure 4.  There was a significant decrease in weight from baseline to 6 months (p<0.0004).  
There was no statistically significant differences between the four different treatment groups for 
percent weight change (p=0.16).   
 
Figure 4: Mean % Change in Weight from Baseline to 6 Months 
 
An analysis of covariance was completed to examine if the change in weight influenced 
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the reduction in hs-CRP remained statistically significant (p=0.039).  Moreover, after controlling 
for weight change, the three-way interaction (time x prescribed energy expenditure x exercise 
intensity) remained statistically significant (p=0.033) (Table 5).   
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Table 5: Effect of Exercise on hs-CRP Controlling for Change in Body Weight 
Outcome 
Variable 
HIGH/VIG 
(N=49) 
(Mean±SD) 
HIGH/MOD 
(N=42) 
(Mean±SD) 
MOD/MOD 
(N=45) 
(Mean±SD) 
MOD/VIG 
(N=46) 
(Mean±SD) 
Time Effect 
(BL to 6M) 
Time X 
PAEE 
Time X 
Intensity 
Time, 
PAEE& 
Intensity 
F 
value 
P 
value 
F 
value 
P 
value 
F 
value 
P 
value 
F 
value 
P 
value 
hs-CRP 
baseline 
5.54±4.98 5.85±6.39 5.16±4.25 5.37±3.85 
.338 039 037 85 .262 26 .609 033 
hs-CRP 
6 mos. 
5.02±4.61 3.75±5.36 4.23±3.9 3.93±2.65 
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4.4 INFLUENCE OF CHANGE IN PERCENT BODY FAT OR CHANGE IN BODY 
FAT DISTRIBUTION ON THE EFFECT OF THE EXERCISE INTERVENTION ON 
CHANGE IN CRP  
 
The change in percent body fat is illustrated in Figure 5.  There was a significant decrease in 
percent body fat from baseline to 6 months (p<0.0004); however, there was no significant 
difference between the groups for the change in percent body fat (p=0.303).  There was a 
significant decrease in waist circumference, (p<0.0004) (see Figure 6), and the reduction in waist 
circumference was significantly different between the intervention groups (p=0.02).  A Scheffe 
post-hoc analysis showed a significantly greater reduction in waist circumference in HIGH/MOD 
compared to MOD/MOD (p=0.048) (see Figure 6).   
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Figure 5: Mean % Change in Body Fat from Baseline to 6 Months 
 
* p=0.048 
Figure 6: Mean Change in Waist Circumference Baseline to 6 Months 
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An analysis of covariance was completed to examine if either a change in body fat or a 
change in fat distribution influenced the effect on change in hs-CRP.    When controlling for 
body fat and a change in body fat distribution, the reduction in hs-CRP remained statistically 
significant (p=0.018 and p<0.0004 respectively).  Moreover, the 3-way interaction (time x 
prescribed energy expenditure x exercise intensity) for change in hs-CRP remained statistically 
significant (see Table 6 and Table 7). 
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Table 6: Effect of Exercise on hs-CRP Controlling for Change in Percent Body Fat 
Outcom
e 
Variable 
HIGH/VI
G 
(N=49) 
Mean±SD 
HIGH/MO
D 
(N=42) 
Mean±SD 
MOD/MO
D 
(N=45) 
Mean±SD 
MOD/VIG 
(N=46) 
Mean±SD 
Time Effect 
(BL to 6M) 
Time X 
PAEE 
Time X 
Intensity 
Time, PAEE & 
Intensity 
F value P 
value 
F 
value 
P 
valu
e 
F 
value 
P 
value 
F 
value 
P 
value 
hs-CRP 
baseline 
5.54±4.98 5.85±6.39 5.16±4.25 5.37±3.85 5.682 0.02 0.001 0.66 0.870 0.352 3.923 0.049 
hs-CRP 
6 mos. 
5.02±4.61 3.75±5.36 4.23±3.9 3.93±2.65         
 
 
 
 
 
Table 7: Effect of Exercise on hs-CRP Controlling for Change in Body Fat Distribution (Waist Circumference) 
Outcome 
Variable 
HIGH/VI
G(N=49)
Mean±SD 
HIGH/MO
D 
(N=42) 
Mean±SD 
MOD/MO
D 
(N=45) 
Mean±SD 
MOD/VI
G 
(N=46) 
Mean±SD 
Time Effect 
(BL to 6M) 
Time X 
PAEE 
Time X 
Intensity 
Time, PAEE 
& Intensity 
F 
value 
P 
value 
F 
value 
P 
valu
e 
F 
value 
P 
valu
e 
F 
valu
e 
P 
value 
hs-CRP 
baseline 
5.54±4.98 5.85±6.39 5.16±4.25 5.37±3.85 1
3.651 
0
.0004 .25 .86 .206 .28 .315 .039 
hs-CRP 
6 mos. 
5.02±4.61 3.75±5.36 4.23±3.9 3.93±2.65         
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4.5 CORRELATIONS BETWEEN SELF-REPORTED PHYSICAL ACTIVITY AND 
CHANGE IN HS-CRP 
 
Self-reported physical activity was not correlated with change in hs-CRP.  There was no 
influence from the change in body weight, percent body fat, or waist circumference on the 
association between hs-CRP and self-reported physical activity (Table 8).  Similar results were 
found when only those subjects with a baseline hs-CRP >3.0 mg/L were examined (Table 9).  
High sensitivity CRP at six months was correlated with weight, BMI, % body fat and fat 
distribution (waist circumference).  There was no correlation with physical activity or when 
controlling for body weight, BMI, percent body fatness, and waist circumference (Table 10).  
Table 8: Pearson Correlation Coefficients Between 6 month Change in hs-CRP and Change 
in Self-Reported Physical Activity, Weight, Body Fatness, and Waist Circumference 
 
 Change in hs-CRP P-Value 
Change in weight (kg) 
 
r = 0.023 0.76 
Change in BMI (kg/m2) 
 
r =0.038 0.61 
Change in % body fat 
 
r =0.021 0.783 
Change in waist circumference (cm) 
 
r = 0.044 0.56 
Change in physical activity (kcal/week) 
 
r = -0.007 0.93 
Change in PAEE controlling for change in % 
body fat 
r = -0.003 0.97 
Change in PAEE controlling for change in 
fat distribution 
r = -0.010 0.90 
Change in PAEE controlling for change in 
weight 
r = -0.010 0.89 
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Table 9: Pearson Correlation Coefficients Between 6 Month Change in hs-CRP and 
Change in Self-Reported Physical Activity, Weight, Body Fatness, Waist Circumference for 
Individuals with CRP >3.0 mg/L   (N=114) 
 Change in hs-CRP P-Value 
Change in weight (kg) 
 
-0.044 0.640 
Change in BMI (kg/m2) 
 
-0.054 0.569 
Change in % body fat 
 
-0.075 0.429 
Change in waist circumference (cm) 
 
0.057 0.549 
Change in physical activity (kcal/week) 
 
-0.003 0.979 
Change in PAEE controlling for change in % 
body fat 
-0.004 0.966 
Change in PAEE controlling for change in 
fat distribution 
-0.004 0.968 
Change in PAEE controlling for change in 
weight 
-0.008 0.936 
 
Table 10: Pearson Correlation Coefficient Between hs-CRP and Self-Reported Physical 
Activity, Weight, Body Fatness, and Waist Circumference 
 hs-CRP measured at 6 
months 
P-Value 
Weight (kg) at 6 months 
 
r = 0.293 p<0.00
04 
BMI (kg/m2) at 6 months 
 
r =0.416 p<0.00
04 
% Body Fat at 6 months 
 
r =0.417 p<0.00
04 
Waist circumference at 6 months 
 
r = 0.304 p<0.00
04 
Physical Activity (kcal/week) at 6 months 
 
r = -0.075 0.31 
Physical Activity at 6 months controlling for 
weight (kg) at 6 months 
r = -0.030 0.69 
Physical Activity at 6 months controlling for 
BMI at 6 months 
r = -0.001 0.97 
Physical Activity at 6 months controlling for 
% body fat at 6 months 
r = -.035 0.65 
Physical Activity at 6 months controlling for 
waist circumference at 6 months 
r = 0.001 0.99 
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5.0  DISCUSSION 
 
This study was a secondary analysis of existing data to examine the influence of physical 
activity, when included within a comprehensive behavioral weight loss program, on change in 
hs-CRP in overweight and obese women over an intervention period of 6 months.  The parent 
study was a randomized trial that used a combination of exercise and reduced caloric intake to 
promote weight loss.  The exercise intervention included a program based on intensity (moderate 
or vigorous) and prescribed energy expenditure (either 1000 kcal or 2000 kcal/week).  The 
women were also instructed to reduce their caloric intake and dietary fat intake.   
Obesity is associated with increased levels of pro-inflammatory markers such as IL-6 and 
TNF-α27-28 and a decrease in the anti-inflammatory cytokine, adiponectin29 resulting in a pro-
inflammatory state.  C-reactive protein is an acute phase protein produced by the liver in 
response to the inflammatory marker, IL-669 and may be associated with atherosclerotic plaque 
formation70.  Thus, obesity is considered a risk factor for CHD6-10 and is associated with an 
increase in morbidity and mortality11.   
A significant body of literature examining weight loss and exercise in relation to 
decreasing CRP levels exists32-40. Those existing studies did not examine the effect of various 
intensities of exercise or the effect of varying the amount of energy expended on CRP levels.  
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This study examined whether altering the prescribed dose of exercise in combination with an 
energy restricted diet resulted in a greater decrease in CRP levels.   
Results from this study indicated that hs-CRP decreased over the six month intervention 
period (see Table 3), with weight loss induced by the combination of increased energy 
expenditure from exercise and a decrease in energy intake.  Selvin et al.92 completed a review of 
the literature to examine the association between change in weight and change in CRP.  Results 
were favorable suggesting that weight loss may be an effective non-pharmacologic strategy for 
decreasing CRP levels.  Selvin and colleagues found on average that the largest change in weight 
was associated with the greatest decrease in CRP levels92.  In contrast, the current study did not 
show a significant association with magnitude of change in weight, BMI, percent body fat, or 
waist circumference and change in hs-CRP (See Table 8).  However, the current study did show 
a significant association between absolute weight at 6 months and hs-CRP at 6 months (see 
Table 10), suggesting that excess body weight may contribute to higher levels of hs-CRP, which 
may increase risk for cardiovascular disease. 
Esposito38 et al. completed a single blind randomized trial examining the effects of a low-
energy Mediterranean-style diet versus a control group.  One hundred and twenty pre-
menopausal women age 20-46 years without a history of diabetes, hypertension, or 
hyperlipidemia participated in the study.  After two years, BMI decreased more in the 
intervention group with a decrease in mean weight of 14 kg and a decrease in CRP levels of 1.1 
mg/L.  The magnitude of the decrease in CRP was correlated with the magnitude of the decrease 
in BMI.  These findings are in contrast to data from the current study that did not show a 
significant association between the magnitudes of weight loss or loss of body fat and the change 
in hs-CRP (see Table 8).   
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Giannopoulou et al.39 randomized 33 obese sedentary women with Type 2 diabetes to 1 
of 3 groups: diet, exercise, or combined diet and exercise group.  Weight loss was 4.6 ± 1.4 kg 
weight loss (5.2% decrease in body fat), 1.7± 0.8 kg (4.7% decrease in body fat), and 5.4 ± 1.3kg 
(5.4% decrease in body fat) in these three intervention group, respectively. There was also a 
significant decrease in CRP levels (approximately 15%) in all three groups with no significant 
differences between the groups39.  Thus, these results do not appear to show an association 
between the magnitude of weight loss and change in CRP, which is similar to the results of the 
current study that also shown no significant association between the magnitude of weight loss 
and change in hs-CRP (see Table 8).  In contrast to the findings of Giannopoulou et al.39, 
Nicklas34 completed a randomized control trial consisting of control group, diet only group, and 
diet and exercise (combination aerobic exercise and resistance training) group and only reported 
a significant decrease in CRP at 18 months with a diet induced-weight loss intervention that 
resulted in a decrease in weight from baseline of 5.7%.  The weight loss of 4.4% resulting from 
diet plus exercise and the weight loss of a 2.6% decrease resulting from exercise alone did not 
result in a significant reduction in CRP from baseline.  These differences in findings between 
studies warrant further investigation.   
This study also showed that when coupled with a reduction in energy intake to induce 
weight loss, there may be a differential effect of exercise on hs-CRP that is dependent on the 
intensity and volume of the exercise performed (see Table 4).  We found a statistically 
significant decrease of 2.10 mg/L,  in the group of women who were prescribed exercise at a 
moderate intensity and progressed to 2000 kcal/week, and the group prescribed exercise at a 
vigorous intensity and progressed to 1000 kcal/week (-1.44 mg/L).  The smallest reduction in hs-
CRP was observed in the group prescribed to exercise at a vigorous intensity and to expended 
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2000 kcal/week, (decrease of 0.52 mg/L), and the moderate intensity/ moderate energy 
expenditure had a 0.93 mg/L reduction in hs-CRP.  However, based on correlational analysis, 
this study did not show a significant association between change in physical activity from 
baseline to 6 months and change in hs-CRP (see Table 8).  These results are not consistent with 
cross-sectional studies showing that higher levels of physical activity (>180 min/week35 and 
expending > 7kcal/min103) were associated with lower levels of CRP.  
 Results from prior studies have shown conflicting results for the effect of exercise on 
change in CRP.  Bassuk and Manson found that CRP levels were decreased in both men and 
women who participated in moderate intensity exercise33.  Milani et al.41, Goldhammer et al.42, 
and Caulin-Glaser et al.43 also demonstrated a decrease in CRP levels in their cardiac 
rehabilitation patient population.  Hambrecht85 and colleagues completed a randomized trial in 
stable CAD patients and demonstrated a decrease in CRP levels.  These studies showed that 
increasing exercise during a cardiac rehabilitation program is successful in decreasing levels of 
CRP.   
Campbell et al.87 and Church et al.45 did not find significant changes in CRP in healthy 
individuals participating in an aerobic exercise intervention.  Both of these trials controlled for 
weight loss and individuals were instructed to maintain the same diet throughout the trial 
preventing weight loss from occurring.  In contrast, Stewart et al.46 completed a randomized 
control trial examining 3 different doses of aerobic exercise with energy expenditure of 4, 8, or 
12 kcal/kg/week.  There was no significant change in CRP among the exercise groups, but 
change in weight was significantly associated with change in CRP.  The group with the greatest 
weight loss (5.9 ± 3 kg) had a significant decrease in CRP46.    This suggests that for exercise to 
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result in significant reductions in CRP, the exercise may need to result in a significant decrease 
in body weight.   
Unfortunately, the current study did not include a group that reduced weight only through 
a reduction in energy intake without exercise, or exercise groups that were not also prescribed a 
reduction in energy intake.  Therefore, it is difficult to make direct comparison to these prior 
exercise studies to determine the magnitude of change in hs-CRP that resulted from exercise in 
the current study.  However, examination of the association between change in physical activity 
and change in hs-CRP after controlling for either change in body weight or change in other 
measures of body composition showed no significant association between physical activity and 
hs-CRP in this current study.       
The differences across studies with regard to the effect of exercise on CRP may be a 
result of the volume or intensity of exercise resulting in an increase in inflammation, as measured 
by CRP, or a blunting of a decrease in CRP as some have hypothesized with weight loss.  For 
example, Taylor et al.104 et al. found that  CRP levels in trained athletes were approximately 13.9 
mg/L, which is a level that is above acceptable clinical levels, (> 10 mg/L signifies an 
inflammatory state)20.  The authors concluded that the elevated CRP may have been a result of 
the response to chronic strenuous exercise.  Moreover, after competing in a 160 km triathlon, 
CRP levels were increased by 300% 24 hours after the race.  Okita et al.105 enrolled healthy 
Japanese women into a 2 month exercise program to promote weight loss.  The exercise 
consisted of 80 minutes of a dance program completed twice per week followed by an additional 
30-60 minutes of additional treadmill or cycling exercises at 60-80% maximum heart rate.  This 
program resulted in a mean weight loss of 3 kg and a significant reduction in CRP (0.22 mg/L).  
However, the investigators reported that the decrease in CRP was not proportionally associated 
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with weight reduction with the quartile of participants with the largest weight reduction not 
having a significant decrease in CRP levels, whereas those with a moderate amount of weight 
loss showing a significant decreases in CRP105.  The investigators hypothesized that the 
strenuous exercise may have blunted the decrease in CRP that was observed with weight loss.  
By comparison, in the current study, hs-CRP was not decreased significantly in the intervention 
group prescribed exercise at a more vigorous intensity (70-85% of maximal heart rate) and for a 
higher energy expenditure (2000 kcal/wk); however, it was decreased significantly in the group 
prescribed exercise at a more vigorous intensity while at a energy expenditure (1000 kcal/wk).  
This may suggest that it is not necessarily the intensity of the exercise that influences changes in 
hs-CRP with weight loss, but rather the influence of both intensity and duration.  This 
observation warrants further investigation.   
 
5.1 LIMITATION AND FUTURE DIRECTIONS 
 
This study was a secondary analysis of a prior study with the focus of implementing various 
intensities and doses of exercise to promote weight loss.  There are several limitations to this 
study that may have influenced the outcomes, which also provides insight into areas to consider 
for future research. 
1. The sample was limited to the subjects who provided serum samples at baseline 
and at 6 months.  Whether results would be different with a longer intervention 
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period is unclear. Therefore, future studies should consider extending beyond a 
period of 6 months. 
2. This study did not include a no treatment control group, a diet only comparison 
group, or exercise groups that did not include a change in prescribed energy 
intake. Therefore, this study cannot determine the independent effect of energy 
restriction, energy expenditure from exercise, or weight loss on the observed 
changes in hs-CRP. Future studies should consider the optimal control and 
comparison groups to allow for a more thorough understand of weight loss, 
energy intake, and energy expenditure on hs-CRP. 
3.  There are a variety of over the counter and prescription medications that could 
influence hs-CRP. Data on medication usage is unavailable for this study.  Thus, 
future studies should collected data on medication usage by the participants to 
control for any effect that these may have on change in hs-CRP. 
4. This study was limited to women, which limits the generalizability of these results 
to men.  Future studies should consider designs with sufficient samples of men 
and women to examine gender comparisons for changes in hs-CRP results from 
weight loss, exercise, and dietary changes. 
5.  The sample for this study consisted of individuals who primarily self-identified as 
Caucasian.  This limits the generalizability of these results to other race/ethnic 
groups, which should be examined in future studies. 
6.  The mean age of the participants in this study was 37.5 ± 5.6 years.  Whether 
similar results would be observed in individuals who are younger or older is 
unclear and should be the focus of future research. 
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7. The measures of physical activity were based on self-report using a questionnaire, 
which may introduce error into this assessment.  Future studies should include 
objective assessment of physical activity. 
8. Participants were instructed to refrain from any physical activity 12 hours prior to 
blood collection.  Aside from self-report, this study was unable to objectively 
confirm that participants were compliant with this directive.  There is evidence 
that shows that both the intensity and duration of exercise results in an increased 
production of IL-6 106-109.  Future studies should recommend a longer time period 
for abstention of exercise prior to blood draws. 
9. The study examined hs-CRP as a marker of inflammation.  It is important to note 
that there are other markers of inflammation such as IL-6 and TNF-α that may 
respond differently to exercise, dietary change, or weight loss.  Future 
examination of additional markers of inflammation in future studies is 
recommended. 
5.2 CONCLUSIONS 
The results of this study showed that hs-CRP was reduced in overweight and obese women in 
response to a 6 month weight loss intervention that included a prescribed reduction in energy 
intake and a prescribed increase in exercise.  Moreover, this study found that varying doses or 
intensities of exercise prescribed within the context of this weight loss intervention differentially 
influenced the observed reduction in hs-CRP.  Whether there is an optimal dose or intensity of 
exercise that should be prescribed to elicit weight loss while also reducing markers of 
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inflammation in overweight and obese adults cannot be determined from this study.  Moreover, 
the added influence of exercise when combined with a reduction in energy intake on hs-CRP 
cannot be determine from this study, and it appears that there are mixed results published in the 
literature on the influence of exercise on CRP.  Thus, further research is needed to identify the 
effect that exercise may have on markers of inflammation, whether there is an optimal dose or 
intensity of exercise that will precipitate changes in these markers of inflammation, and the 
combine and independent influence of exercise and weight loss on markers of inflammation in 
overweight and obese adults.  
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